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Background: Older people have the highest incidence of acute medical admissions. Old age and acute hospital
admissions are associated with a high risk of adverse health outcomes after discharge, such as reduced physical
performance, readmissions and mortality. Hospitalisations in this population are often by acute admission and
through the emergency department. This, along with the rapidly increasing proportion of older people, warrants
the need for clinically feasible tools that can systematically assess vulnerability in older medical patients upon acute
hospital admission. These are essential for prioritising treatment during hospitalisation and after discharge.
Here we explore whether an abbreviated form of the FI-Lab frailty index, calculated as the number of admission
laboratory test results outside of the reference interval (FI-OutRef) was associated with long term mortality among
acutely admitted older medical patients. Secondly, we investigate other markers of aging (age, total number of
chronic diagnoses, new chronic diagnoses, and new acute admissions) and their associations with long-term
mortality.
Methods: A cohort study of acutely admitted medical patients aged 65 or older. Survival time within a 3 years
post-discharge follow up period was used as the outcome. The associations between the markers and survival time
were investigated by Cox regression analyses. For analyses, all markers were grouped by quartiles.
Results: A total of 4,005 patients were included. Among the 3,172 patients without a cancer diagnosis, mortality
within 3 years was 39.9%. Univariate and multiple regression analyses for each marker showed that all were
significantly associated with post-discharge survival. The changes between the estimates for the FI-OutRef quartiles in
the univariate- and the multiple analyses were negligible. Among all the markers investigated, FI-OutRef had the highest
hazard ratio of the fourth quartile versus the first quartile: 3.45 (95% CI: 2.83-s4.22, P < 0.001).
Conclusion: Among acutely admitted older medical patients, FI-OutRef was strongly associated with long-term mortality.
This association was independent of age, sex, and number of chronic diagnoses, new chronic diagnoses, and new acute
admissions. Hence FI-OutRef could be a biomarker of advancement of aging within the acute care setting.* Correspondence: Henrik.Klausen@regionh.dk
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Acutely admitted older medical patients have high risks
of low physical reserve capacity, comorbidities, chronic
diseases, recurring admissions, and mortality [1–6]. The
prevalence of chronic disease increases with age and is
associated with poorer functional status, lower quality of
life, and increased mortality risk [6]. The rate of new
chronic disease also increase with age, and with level of
chronic inflammation [7]. Age and elevated inflamma-
tion are associated with recurring admissions, frailty,
and time to death [8, 9]. In older patients, activities of
daily living decline in conjunction with acute hospitalisa-
tion, and this decline persists in a majority of patients
one year after discharge [10–12]. This may be caused by
vulnerability due to advanced biological aging with high
accumulation of deficiencies and reduced stability in
homeostatic balance, reducing the threshold for coping
with stress [9, 13–17].
There is no gold standard for assessing the progression
of biological aging or frailty. Long-term mortality – in the
sense of time to death not owing to a lethal accident or
acute illness, and hence solely reflecting the increasing
mortality risk associated with aging – is a feasible way to
measure the progression of biological aging and frailty
[18, 19]. However, it is not clinically applicable.
A clinically applicable tool to systematically identify
patients with advanced biological aging upon admission to
an emergency department could help prioritise medical
treatment, care, and rehabilitation during hospitalisation
and following discharge. To assess the risk of long-term
mortality in a clinical setting, biomarkers that reflect the
cellular processes of aging at the organism level, across
acute illnesses, chronic diseases, and social inequality are
needed. For clinical use, biomarker measurement must be
simple, reproducible, and able to be performed in an
emergency department, from where a substantial number
of older patients are discharged [20–22].
Quantification of accumulated deficiencies – by frailty
index (FI) [23, 24] and physiological dysregulation -by DM
[17] are comprehensive measures of aging related changes
on the organism level. They are based on the concept that
assessment of aging needs to reflect the sum of the many
different intracellular and intercellular aging changes,
which drive aging at the organism level. Variables of aging
changes, which are not individually significantly associated
with time to death, can be essential for assessing the pro-
gression of aging at the organism level. FI is a generic
measure as its association with the risk of death, institutio-
nalisation, and worsening health status is reproducible in-
dependent of the types of aging-related variables included
in the frailty index, especially if 30 variables or more are
included [24]. The DM’s association with frailty and mor-
tality is also reproducible with many different clusters of
aging related variables [25, 26]. FI is calculated as thenumber of variables over or under a given deficiency
threshold for the specific variable, making FI readily clin-
ical applicable. The DM being a multivariate statistical dis-
tances among sets of biomarkers relatively to the mean of
a reference population is more challenging within a clin-
ical setting. The FI have been validated in different popu-
lations of mainly community-dwelling individuals [27–31].
One frailty index consisting of common clinical labora-
tory tests with the addition of blood pressure variables
(the laboratory frailty index (FI-Lab)) has to our know-
ledge not yet been tested within an acute care clinical
setting [27, 28, 30]. Acute illness could potentially offset
laboratory test results, hence acute illness could be a
bias for assessing frailty and advancement of aging by
accumulated deficiency in admission laboratory tests.
On the other hand, if acknowledging that frailty in-
cludes reduced reserve capacity to cope with stress, the
number of laboratory test results outside of the refer-
ence interval in admission blood samples, could poten-
tially reflect high susceptibility to stress by the acute
illness, and hence frailty.
A frailty index composed of 53 variables, of which 18
were the product of common clinical laboratory tests,
showed significant association with mortality within 300
days of hospitalisation in older patients in a specialised
geriatric intensive care unit [32].
Routine admission laboratory tests from the acute care
setting in older medical patients have mainly be tested for
their association with —and have acceptable predictive abil-
ity for—short-term or in-hospital mortality in conjunction
with an acute illness [33–38]. However, their association
with long-term mortality is unknown.
We hypothesised that an abbreviated form of FI-Lab -
based entirely on standard admission laboratory test results
outside of the reference interval (henceforth referred to as
FI-OutRef), would be associated with long term mortality
in acutely admitted older medical patients.
The objectives of the current study were, first, to explore
whether FI-OutRef was associated with long-term mortal-
ity risk among acutely admitted older medical patients; and
secondly, to investigate how chronological age, the total
number of chronic diagnoses, and the numbers of new
chronic diagnoses and new acute admissions in the 2-year
period preceding admission (henceforth referred to as age,
number of chronic diagnoses, new chronic diagnoses, and
new acute admissions) were associated with survival after
discharge. Thirdly, we aimed to compare all five markers
of long-term mortality risk.
Methods
Design
We conducted a cohort study from administrative and clin-
ical databases. All patients of 65 years of age or older with
an acute medical admission to the Emergency Department
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between January 1st 2010 and December 31st 2010 were
included. The index hospitalisation was defined as the first
acute medical admission during this period. Two hospita-
lisations within 4 hours of each other were defined as one.
We collected data regarding in-hospital and out-patient
clinical care for 10 years prior to - and 3 years following -
the index hospitalisation with a uniform pre- and post-
hospitalisation observation period, regardless of the time
of admission in the inclusion period. This investigation
was approved by the local Danish Data Protection Agency
(journal no HVH-2011-14) and the Research Ethics
Committees for The Capital Region of Denmark (H-1-
2011-FSP). Our reporting of this study adheres to the
STrengthening the Reporting of OBservational studies in
Epidemiology (STROBE) guidelines, using the checklist
for cohort studies [39].
Setting
Denmark has a public healthcare system that provides all
citizens with uniform, feeless, tax-funded treatment for
primary medical care, hospital care and homecare ser-
vices. All Danish citizens have a unique personal identifi-
cation number, making it possible to track citizens in
various national registers.
Acute admission is only provided when the need is de-
termined by a general practitioner, or by ambulance staff
following an emergency call. Copenhagen University Hos-
pital, Hvidovre, has a 552-bed capacity, and had 13,024
acute admissions to its emergency department in 2010.
For acutely admitted patients, the emergency department
performs a standard panel of laboratory tests, including
C-reactive protein, leukocytes, differential blood count,
haemoglobin, mean corpuscular haemoglobin concentra-
tion, mean corpuscular volume, thrombocytes, creatinine,
blood urea nitrogen, sodium, potassium, albumin, alanine
aminotransferase, alkaline phosphatase, lactate dehydro-
genase, bilirubin, and coagulation factors II, VII, and X.
When hospitalisation is not required, medical investiga-
tion of new symptoms and treatment of chronic diseases
are carried out at hospital outpatient clinics by the appro-
priate medical specialties. The Danish National Patient
Register includes information regarding patients’ diagno-
ses from hospitalisations and outpatient visits, but not
from visits to general practitioners. The Danish Civil
Registration System provides updated information on vital
status by the citizen’s personal identification number.
Details on both national registers have previously been
provided [40, 41].
Covariates and outcome variables
We focused on five markers that are strongly or potentially
associated with long-term mortality: 1) FI-OutRef, reflect-
ing overall organism dysfunction due to accumulateddeficiencies in multiple organ systems; 2) age; 3) number of
chronic diagnoses, reflecting accumulated morbidity; 4) new
chronic diagnoses, reflecting the rate of comorbidity; and 5)
new acute admissions, reflecting the severity of disease and
impairment.
FI-OutRef was calculated based on the routine panel of
17 laboratory tests undertaken in the emergency depart-
ment at the index hospitalisation. We identified test results
outside of the laboratory’s age- and sex-specific reference
intervals (See Additional file 1: Appendix 1 for overview
and references). FI-OutRef was calculated for a patient
only if data were available for ≥10 of the 17 tests. When
data were missing for seven or fewer of the 17 laboratory
tests, FI-OutRef was standardised by dividing the number
of tests with out-of-reference-interval results by the num-
ber of tests performed, and multiplying this number by 17.
The number of chronic diagnoses was calculated as the
number of unique chronic diagnosis codes during the
10-year period prior to the index hospitalisation. New
chronic diagnoses were calculated as the number of new
unique chronic diagnosis codes recorded for the patient
during the 2-year period preceding the index hospitalisa-
tion. Chronic diagnoses were identified within all diagnoses
from hospitalisations and outpatient clinic visits in the Da-
nish National Patient Register database. A chronic diagnosis
was classified using the Healthcare Cost and Utilisation
Project’s Chronic Condition Indicator (CCI) tool [42, 43].
The CCI is a dichotomised assessment of United States
(US) ICD10 diagnosis codes as chronic or non-chronic,
with ‘chronic’ defined as a condition lasting ≥12 months
and meeting one or both of the following criteria: “(a) it
places limitations on self-care, independent living, and so-
cial interactions; (b) it results in the need for ongoing inter-
vention with medical products, services, and special
equipment” [42]. To account for differences between the
US and Danish ICD10 sub-classifications, an algorithm was
developed for identifying chronic diagnoses in the cohort. If
the diagnosis code from the CCI classification was identical
to the patients’ ICD10 code (only considering number of
digits used in the CCI classification), the patients were
assigned the same CCI classification. Diagnosis codes that
did not match the CCI classification were independently
reviewed by two physicians (HHK and OA). We reviewed a
list of matching diagnoses between the US ICD10 and
Danish ICD10 by the first four characters to find matching
specific diagnosis names, and assigned the relevant CCI
classification to the Danish ICD10 code. We also reviewed
a second list of 450 Danish ICD10 codes, with no matching
US ICD10 codes at the four-character level, and classified
these codes in accordance with the Healthcare Cost and
Utilisation Project’s definition of chronic disease by consen-
sus of the two physicians.
New acute admissions were calculated as the accumu-
lated number of acute admissions recorded in the
Klausen et al. BMC Geriatrics  (2017) 17:62 Page 4 of 14Danish National Patient Register within the 2-year
period prior to the index hospitalisation.
Time to death during in-hospital stay and post-discharge
were calculated based on the vital status extracted from the
Danish Civil Registration System. Charlson Comorbidity
Index score was calculated based on all diagnoses registered
in the 10-year period prior to the index hospitalisation [44].
Length of stay was defined as the time between admission
and discharge. Length of stay was calculated for the index
hospitalisation, as well as accumulated for all hospitalisa-
tions and for all acute hospitalisations during the 10-year
period prior to the index hospitalisation.
Statistical analysis
Separate analyses were performed for patients with and
without a cancer diagnosis within the 10-year period
prior to the index hospitalisation, identified by ICD10
codes containing C00–C96. To better compare the re-
sults for the five markers, they were each categorised
into the nearest possible quartiles.
Cumulative incidence plots were generated to visualise
associations between the five markers and post-discharge
time to death among non-cancer patients. Censoring was
made 3 years after discharge. Cumulative incidence plots
were also used to investigate associations between the five
markers and in-hospital time to death among non-cancer
patients. Discharge was considered a competing event to
in-hospital death.
Among non-cancer patients, survival analyses for each
of the five markers with regard to post-discharge time to
death were carried out using Cox regression analyses.
These analyses were performed without adjustment, ad-
justed for each of the four other markers, and in a fully
adjusted model including all five markers and sex. The
first quartile of each marker was used as the reference
for all analyses.
FI-OutRef had more missing values than the other
four markers. Thus, we performed sub-analyses for these
four covariates to investigate the effects of potential se-
lection bias. For this, we compared the estimates of the
unadjusted analyses of the total cohort to that of the
subpopulation with no missing data for FI-OutRef, for
each of the other four markers.
To study possible modification effects among the five
markers, as well as possible modification effects of sex
on the effects of the five markers, we extended the full
models for post-discharge time to death to include inter-
actions between pairs of markers, and between sex and
each marker.
To make FI-OutRef more clinically applicable, we esti-
mated the optimal cut point for the current data using the
Youden index. In a set of secondary analyses, we investi-
gated each laboratory test for potentially carrying the main
effect of the association between FI-OutRef and post-discharge time to death. The laboratory tests were ranked
according to the disproportion in death 3 years from
discharge between patients having the test result inside
versus outside the reference interval. FI-OutRef was made
a categorical covariate in accordance with the Youden
index-identified cut-off level with the highest specificity
and sensitivity for predicting time to post-discharge death
[45]. Cox regression analyses for time to death were then
performed with the categorical FI-OutRef adjusted for
each of the seven highest ranking tests of the above-
mentioned laboratory tests, as well as with a fully adjusted
model in which FI-OutRef was adjusted for all of the
seven highest ranking laboratory tests.
For patients with cancer diagnoses, we analysed the as-
sociations of the five markers with post-discharge and
in-hospital time to death using cumulative incidence
plots similar to those constructed for the non-cancer
patients.
Statistical analyses were performed using the SAS en-
terprise guide 6.1 packages (SAS Institute, Cary, NC,
USA). Cumulative incidence plots were generated using
the analysis package ‘cmprsk’ version 2.2-7 in R Version
3.1.1 (R Foundation, Vienna, Austria).Results
Study flow and patient characteristics
A total of 4,005 patients above 65 years of age were acutely
admitted to the Emergency Department at the Copenhagen
University Hospital, Hvidovre, in 2010. Of these patients,
833 had a prior or current cancer diagnosis. In-hospital and
post-discharge (3-year follow-up) mortality proportions, re-
spectively, were 6.5% and 39.9% among the 3,172 patients
without a cancer diagnosis, and 8.8% and 54.9% for the 833
patients with a current or prior cancer diagnosis. Table 1
presents the descriptive data for the non-cancer and cancer
patients.Markers and post-discharge mortality among non-cancer
patients
Visual interpretation of the cumulative incidence plots re-
vealed the clearest separation between quartiles for FI-
OutRef and age compared with the other markers
(Fig. 1a–e). Both were without any overlapping confidence
intervals (CI) 3 years post-discharge (See Additional file 2:
Appendix 2 for overview of CI of cumulated incidence).
For the number of chronic diagnoses, the first quartile was
the only quartile with no overlapping CI (Fig. 1c). For new
chronic diagnoses, the fourth quartile had the highest cu-
mulative incidence for death within 3 years post-discharge
and was the only quartile with a CI that did not overlap
with the nearest quartile’s CI (Fig. 1d). For new acute
admissions, quartile two and quartile three had non-
overlapping CIs, while the CIs overlapped between quartiles
Table 1 Characteristics of the study population
Non-diagnosed cancer Diagnosed cancer
Variables N Median IQ N Median IQ
Sex female (%) 1884 59% 422 51%
LOS Index (days) 3172 3.0 1.0 - 8.0 833 3.00 1.0 - 8.0
Charlson Score (No.) 3172 1.0 0.0 - 2.0 833 3.00 2.0 - 5.0
CRP (mg/l) 2610 14.0 6.0 - 50.0 714 21.0 6.0 - 68.0
Leukocyte (x109/l) 2548 9.1 7.1 - 12.2 700 9.2 7.1 - 12.4
Neutrophils (x109/l) 2539 6.4 4.6 - 9.4 691 6.6 4.6 - 9.8
Haemoglobin (mmol/l) 2545 7.9 7.1 - 8.6 699 7.5 6.6 - 8.2
MCHC (mmol/l) 2519 20.9 20.4 - 21.5 693 20.8 20.2 - 21.3
MCV (Fl) 2519 90.0 87.0 - 94.0 693 90.0 86.0 - 95.0
Thrombocyte (x109/l) 2540 238.0 190.0 - 302.0 698 246.0 189.0 - 322.0
Creatinine (μmol/l) 2622 86.0 69.0 - 116.0 716 85.0 69.0 - 120.5
BUN (mmol/l) 2562 7.0 5.1 - 10.1 696 7.2 5.1 - 10.9
Sodium (mmol/l) 2622 138.0 135.0 - 141.0 716 138.0 134.0 - 140.0
Potassium (mmol/l) 2594 3.8 3.5 - 4.2 706 3.9 3.5 - 4.3
Albumin (g/l) 2592 36.0 32.0 - 40.0 709 35.0 30.0 - 38.0
ALAT (U/l) 2588 17.0 11.0 - 26.0 708 17.0 11.0 - 26.0
Alkaline Phosphatase (U/l) 2572 80.0 65.0 - 105.0 703 86.0 67.0 - 114.0
LDH (U/l) 2496 182.0 156.0 - 220.0 680 186.0 154.0 - 229.5
Bilirubin (μmol/l) 2591 7.0 5.0 - 11.0 705 7.0 5.0 - 11.0
Factor II, VII, X 2528 0.8 0.6 - 1.0 693 0.8 0.6 - 1.0
2000-2010
Diag. Unique 3172 16.0 9.0 - 25.0 833 22.0 14.0 - 32.0
Outpatient clinic visits 3172 8.0 4.0 - 13.0 833 13.0 8.0 - 19.0
Prior admissions 3172 4.0 1.0 - 7.0 833 6.0 3.0 - 10.0
Prior acute admissions 3172 3.0 1.0 - 6.0 833 4.0 2.0 - 7.0
LOS 3172 19.0 4.0 - 50.0 833 30.0 12.0 - 63.0
LOS acute admissions 3172 12.0 1.0 - 36.0 833 18.0 5.0 - 45.0
FI-OutRef (No.) 2607 5.0 3.0 - 8.0 714 6.0 4.0 - 8.5
Age (years) 3172 79.4 72.3 - 85.7 833 79.4 73.0 - 85.6
No. of chronic diag (No.) 3172 6.0 3.0 - 11.0 833 9.0 5.0 - 13.0
New chronic diag (No.) 3172 1.0 0.0 - 3.0 833 2.0 1.0 - 4.0
New acute admissions (No.) 3172 1.0 0.0 - 2.0 833 2.0 1.0 - 4.0
Non-diagnosed cancer no cancer diagnoses registered within 10 years prior to index admission, Diagnosed cancer cancer diagnosis registered within 10 years prior
to index admission, Diag. Unique the number of unique diagnosis codes, LOS length of stay, CRP C-reactive protein, MCHC mean corpuscular haemoglobin
concentration, MCV mean corpuscular volume, BUN blood urea nitrogen, ALAT, alanine aminotransferase, LDH, lactate dehydrogenase, FI-OutRef number of
laboratory tests outside reference interval, No. of chronic diag number of chronic diagnoses within the 10 years prior to the index admission, New chronic diag
number of new chronic diagnoses in the two-year period up to index admission, New acute admissions number of new acute admissions in the two-year period
up to index admission. Bold fonts indicate variables used as markers of long-term mortality
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post-discharge.
Unadjusted Cox regression analyses showed that all
five markers were significantly associated with post-
discharge time to death (P < 0.001). Table 2 shows the
hazard ratios for the investigated markers. Comparing
the markers by their hazard ratios for quartiles two tofour, relative to quartile one, revealed the strongest asso-
ciation with FI-OutRef, followed by age.
When Cox regression analyses were carried out with
adjustment in pairs, the hazard ratios for new chronic diag-
noses were the most altered in comparison with the un-
adjusted analysis. In the analysis of new chronic diagnoses
with adjustment for the number of chronic diagnoses or
Fig. 1 Cumulative incidence plots of mortality within 3 years post-discharge for patients without cancer diagnoses stratified by quartiles (Q1-Q4)
of a: FI-OutRef, b: Age, c: No. of chronic diag., d: New chronic diag and e: New acute admissions. For proportion of cumulative mortality including
95% confidence interval (see Additional file 2: Appendix 2) Abbreviations: FI-OutRef: Frailty index by the number of admission laboratory tests
outside the reference interval. No. of chronic diag: number of unique chronic diagnoses within the 10-year period prior to the index admission.
New chronic diag: The number of chronic diagnoses given in the 2-year period preceding the index admission. New acute admissions: Number
of new acute admissions within the 2-year period preceding the index admission. 1) Note: FI-OutRef includes 2,442 of the 2,965 discharged
patients who had 10 or more standard laboratory tests analysed at admission
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hazard ratio crossed one for all quartiles. The ranking of
the markers according to their hazard ratios between the
fourth and the first quartiles did not differ between the fully
adjusted models and the unadjusted analyses (Table 2).
Among the 3,172 patients without cancer, 2,607
(≈82%) had data available for 10 or more standard ad-
mission laboratory tests. Compared with patients with
available FI-OutRef data, those with missing FI-OutRef
data had a shorter median length of stay (5.0 versus 5.6
days; Kruskal-Wallis test; P < 0.001), a higher proportion
of women (54.3% versus 49.7%; chi-square; P = 0.007),and a lower median age (78.4 versus 79.4 years;
Kruskal-Wallis test; P = 0.004). Cumulative incidence of
in-hospital and post-discharge death, and mean post-
discharge time to death did not significantly differ be-
tween the patients with available and those with missing
FI-OutRef data. Sub-analyses were performed including
only the 2,442 discharged patients with available FI-
OutRef data. The results showed negligible changes in the
hazard ratios or P values for age, number of chronic diag-
noses, new chronic diagnoses, or new acute admissions
compared with the analyses of the full cohort of 2,965
discharged patients (data not shown).
Table 2 Hazard ratios for time to death post-discharge by quartiles of markers in patients without cancer diagnoses
Unadjusted) Adjusted Fully adjusted






FI-OutRef1) P < .0001 P < .0001 P < .0001 P < .0001 P < .0001 P < .0001
Quartile 2 2.09 (1.69–2.58) 1.94 (1.57–2.40) 2.01 (1.62–2.48) 2.05 (1.66–2.54) 2.05 (1.66–2.53) 1.92 (1.55–2.37)
Quartile 3 3.25 (2.65–3.99) 2.84 (2.31–3.49) 3.12 (2.54–3.84) 3.18 (2.60–3.91) 3.18 (2.59–3.90) 2.73 (2.22–3.36)
Quartile 4 4.07 (3.33–4.97) 3.66 (3.00–4.48) 3.85 (3.15–4.71) 4.01 (3.28–4.90) 3.89 (3.18–4.76) 3.48 (2.84–4.26)
Age P < .0001 P < .0001 <.0001 P < .0001 P < .0001 P < .0001
Quartile 2 1.52 (1.26–1.83) 1.41 (1.15–1.74) 1.48 (1.22–1.78) 1.51 (1.25–1.82) 1.51 (1.26–1.82) 1.42 (1.15–1.75)
Quartile 3 2.25 (1.88–2.68) 2.05 (1.69–2.50) 2.13 (1.77–2.53) 2.25 (1.88–2.68) 2.17 (1.82–2.60) 1.99 (1.63–2.42)
Quartile 4 3.60 (3.04–4.27) 3.14 (2.60–3.80) 3.50 (2.95–4.16) 3.69 (3.11–4.38) 3.55 (3.00–4.21) 3.15 (2.60–3.81)
No. of chronic
diagnoses
P < .0001 P < .0001 P < .0001 P < .0001 P < .0001 P 0.07
Quartile 2 1.42 (1.21–1.68) 1.41 (1.18–1.68) 1.31 (1.11–1.54) 1.45 (1.22–1.72) 1.32 (1.12–1.56) 1.28 (1.06–1.54)
Quartile 3 1.66 (1. 40–1.98) 1.56 (1.28–1.88) 1.50 (1.26–1.79) 1.68 (1.39–2.03) 1.42 (1.18–1.71) 1.32 (1.07–1.63)
Quartile 4 1.93 (1.63–2.27) 1.73 (1.43–2.05) 1.82 (1.54–2.14) 1.87 (1.55–2.26) 1.57 (1.31–1.88) 1.44 (1.17–1.78)
New chronic
diagnoses
P < .0001 P < .0001 P < .0001 P 0.060 P < .0001 P 0.029
Quartile 2 0.98 (0.83–1.15) 0.95 (0.79–1.13) 0.98 (0.83–1.16) 0.87 (0.74–1.04) 0.84 (0.71–1.00) 0.84 (0.69–1.02)
Quartile 3 1.09 (0.93–1.27) 1.01 (0.85–1.20) 1.07 (0.92–1.25) 0.88 (0.75–1.05) 0.86 (0.72–1.02) 0.81 (0.66–0.98)
Quartile 4 1.48 (1.27–1.71) 1.33 (1.13–1.57) 1.56 (1.35–1.81) 1.07 (0.90–1.27) 1.03 (0.86–1.23) 1.01 (0.82–1.24)
New acute
admissions
P < .0001 P < .0001 P < .0001 P < .0001 P < .0001 P <0.001
Quartile 2 1.23 (1.06–1.43) 1.15 (0.97–1.35) 1.15 (0.99–1.34) 1.12 (0.96–1.31) 1.27 (1.08–1.49) 1.12 (0.94–1.32)
Quartile 3 1.65 (1.39–1.97) 1.35 (1.11–1.64) 1.53 (1.28–1.82) 1.43 (1.19–1.72) 1.69 (1.39–2.04) 1.23 (0.99–1.53)
Quartile 4 1.87 (1.61–2.17) 1.65 (1.40–1.94) 1.82 (1.57–2.11) 1.57 (1.33–1.85) 1.88 (1.58–2.25) 1.49 (1.22–1.81)
Univariate- and multivariate survival analyses regarding mortality within 3 years from discharge in acutely admitted older medical patients by nearest possible
quartiles of addressed variables. Columns indicate adjusting covariates in the multivariate survival analysis. Fully adjusted model: adjusted for all of the other
addressed covariates and sex. FI-OutRef frailty index by the number of laboratory test results outside the reference interval in the standard panel of laboratory
tests at admission, No. of chronic diagnoses total number of unique chronic diagnoses within the 10-year period prior to the index admission, New chronic
diagnoses, the number of chronic diagnoses given in the 2-year period up to the index admission, New acute admissions number of new acute admissions within
the 2-year period up to the index admission 1) Analyses for FI-OutRef includes 2,442 of the total 2,965 discharged patients who had 10 or more standard
laboratory tests at admission
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of the markers in the survival analyses regarding post-
discharge time to death. Sex was only a significant factor
in the survival analysis focusing on age (P < 0.001). Test-
ing for interactions among the markers with regard to
time to death in the fully adjusted model revealed no in-
teractions among the five markers. When testing the
modifying effect of sex on each of the markers, the only
significant interaction observed was between sex and new
chronic diagnoses (P = 0.02).
Using the Youden index, we determined that an FI-
OutRef of ≥5 was the cut-off value with the highest pos-
sible sensitivity and specificity for predicting death within
3 years post-discharge. Death proportions 3 years post-
discharge were 53.0% for patients with an FI-OutRef of ≥5,
and 24.0% for those with an FI-OutRef of <5 (P < 0.001)
(Fig. 2a). Having an FI-OutRef of ≥5 had a greater impact
on post-discharge mortality than having any individuallaboratory test result outside of its reference interval
(Fig. 2b). The unadjusted survival analysis for post-
discharge time to death showed a hazard ratio of 2.9 (95%
CI: 2.5–3.3, P < 0.001) for having an FI-OutRef of ≥5 com-
pared with <5. When FI-OutRef was adjusted for the seven
laboratory tests with the highest discrimination for 3-year
mortality (blood urea nitrogen, C-Reactive Protein, alka-
line phosphatase, creatinine, neutrophil, albumin, and
haemoglobin), FI-OutRef remained significantly associated
with time to death (HR 1.5 (95% CI: 1.3–1.9);P < 0.001).
Blood urea nitrogen had the highest individual impact on
the hazard ratio of FI-OutRef, changing the estimate to 2.5
(95% CI: 2.1–2.9, P < 0.001).
Markers and in-hospital mortality among non-cancer
patients
For patients without cancer diagnoses, the cumulative
incidence plots of death during in-hospital stay (within
Fig. 2 a The number (#) of patients with admission laboratory test results outside (out) or inside (in) the reference interval (ref) and their
corresponding proportion of mortality within 3 years from discharge. Significance of difference by Chi-Square * ~ P ≤ 0.001, ** ~ P ≤ 0.05.
b differences in the mortality proportion for patients inside versus outside the reference interval. FI-OutRef: Frailty index by the number of
admission laboratory test results outside the reference interval. MCHC: Mean corpuscular haemoglobin concentration. MCV: Mean corpuscular vol-
ume. BUN: Blood urea nitrogen. ALAT: Alanine aminotransferase. LDH: Lactate dehydrogenase. Coag. Fac. II,VII, X: Coagulation factor II, VII and X
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patients had been discharged) revealed that FI-OutRef
showed the clearest separation among quartiles
(Fig. 3a-e). For the cumulative incidence of death for
FI-OutRef, the CI for the third quartile overlapped with
the CI of the fourth quartile, but not with the CIs of
the second or first quartile, which had identical cumu-
lative incidences of death (Fig. 3a) (See Additional file
2: Appendix 2 for overview of CI of cumulated inci-
dence). The cumulative incidences of death within 3
days post-admission for age, number of chronic diagno-
ses, new chronic diagnoses, and new acute admissions
showed no systematic ranking by quartiles, and all CIs
were overlapping (Fig. 3b–e).Markers and mortality among cancer patients
For post-discharge death among patients with cancer
diagnoses only FI-OutRef and new acute admissions
showed any separation of cumulative incidence curves by
quartiles when taking the 95% CI into account (Fig. 4)
(See Additional file 2: Appendix 2 for overview of CI of
cumulated incidence). Cumulative incidences of death
within 3 years post-discharge for the fourth quartiles of
FI-OutRef and new acute admissions were 71.4% and
72.8%, respectively (Fig. 4a & e). For FI-OutRef, the CIs of
cumulative incidence of death within 3 years post-
discharge overlapped between the first and the second
quartiles, and between the third and the fourth quartiles
(Fig. 4a). For new acute admissions, only the first quartile
Fig. 3 Cumulative incidence plots of mortality for in-hospital mortality for patients without cancer diagnoses stratified by quartiles (Q1-Q4) of
a: FI-OutRef, b: Age, c: No. of chronic diag., d: New chronic diag and e: New acute admissions. For proportion of cumulative mortality including
95% confidence interval (see Additional file 2: Appendix 2). Abbreviations: FI-OutRef: Frailty index by the number of admission laboratory test
results outside the reference interval. No. of chronic diag: the number of unique chronic diagnoses within the 10-year period prior to the index
admission. New chronic diag: The number of chronic diagnoses given in the 2-year period preceding the index admission. New acute admissions:
the number of new acute admissions within the 2-year period preceding the index admission. 1) Note: FI-OutRef includes 2,607 of the 3,172
included patients who had 10 or more standard laboratory tests at admission
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quartiles CI (Fig. 4e).
For the cumulative incidence of death during the in-
hospital stay among patients with a cancer diagnosis, none
of the five markers showed any discrimination according
to quartiles. All CIs for these analyses were overlapping
(data not shown).
Discussion
Our results demonstrate that FI-OutRef was strongly as-
sociated with long-term mortality among acutely admit-
ted older medical patients without a cancer diagnosis.This association was independent of sex and of the other
investigated markers: age, number of chronic diagnoses,
new chronic diagnoses, and new acute admissions.
Compared with these other markers, FI-OutRef showed
the highest hazard ratio for its fourth quartile versus its
first quartile, with clear separation from the hazard
ratios of the second and third quartiles. Age had the
second strongest independent association with time to
death post-discharge. Among number of chronic diagno-
ses (reflecting accumulated morbidity), new chronic diag-
noses (reflecting current rate of comorbidity), and new
acute admissions (reflecting severity of impairment and
Fig. 4 Cumulative incidence plots of mortality within 3 years post-discharge for patients with a cancer diagnoses stratified by quartiles (Q1-Q4) of
a: FI-OutRef, b: Age, c: No. of chronic diag., d: New chronic diag and e: New acute admissions. For proportion of cumulative mortality including
95% confidence interval (see Additional file 2: Appendix 2). Abbreviations: FI-OutRef: Frailty index by the number of admission laboratory test
results outside the reference interval. No. of chronic diag: the number of unique chronic diagnoses within the 10-year period prior to the index
admission. New chronic diag: the number of chronic diagnoses given in the 2-year period preceding the index admission. New acute admissions:
the number of new acute admissions within the 2-year period preceding the index admission. 1) Note: Analyses for FI-OutRef includes 714 of the
726 discharged patients who had 10 or more standard laboratory tests at admission
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ity to discriminate patients by time to death. With re-
gard to death during in-hospital stay (within 3 days
post-admission) among patients with no cancer diagno-
sis, only the quartiles of FI-OutRef and age seemed to
discriminate this outcome when evaluated by cumulative
incidence plots.
Patients with a cancer diagnosis within the 10-year
period prior to the index hospitalisation showed higher
rates of overall death within 3 years post-discharge and
during their in-hospital stay compared with patients
without prior cancer diagnoses. Among patients with aprior cancer diagnosis, none of the investigated potential
markers could discriminate patients by cumulative inci-
dence of death 3 days post-admission. In this patient
group, only quartiles of FI-OutRef and new acute admis-
sions could discriminate patients by cumulative inci-
dence of death 3 years post-discharge.
In recent decades, there has been a growing interest in
using routine laboratory tests to predict in-hospital mor-
tality among admitted patients, often in combination
with age and vital parameters, such as alertness, blood
pressure, temperature, heart rate, and respiratory rate
[33, 35–37, 46]. Some laboratory tests are already widely
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for example, the CURB65 [47] and SAPS II score [48],
to assess disease severity in patients with pneumonia
and patients in the intensive care unit, respectively.
Within the acute care setting, only few measures have
been developed to predict survival after discharge, iden-
tifying older medical patients with advanced biological
aging. Those present, are often interview-based assess-
ments of activities of daily living, or other measurements
of functional inactivity, which carry a risk of patient re-
call bias [49–52]. Moreover, the above-mentioned tools
are time-consuming, and as such, a hindrance for imple-
mentation in a time-restrained flow culture such as the
emergency department [52, 53]. The frailty index FI-Lab
consisting of diastolic- and systolic blood pressure in
addition to 21 common laboratory tests, of which 10
were overlapping with the tests in the current study,
have so far not been evaluated in older hospitalised pa-
tients [27]. In community-dwelling and institutionalised
older people, FI-Lab performs as good as of other frailty
indices based on clinical and physical performance vari-
ables, with regard to long-term mortality risk [27, 28, 30].
These clinical frailty indices were composed of accumu-
lated deficiencies by evaluating variables measuring symp-
toms, signs, disabilities and diseases.
The markers investigated in the current study are all
objective measurements that place no extra strain on
emergency department personnel for data collection. The
data required to calculate FI-OutRef are usually readily
available. When assessing biological aging in an acutely
admitted older patient, the patient’s physiological resili-
ence to the stress induced by a given acute disease is an
essential indicator of physical reserve capacity—which, in
turn, is inversely related to the organ dysfunction induced
by biological aging [9, 54]. A laboratory test is typically
only used as a clinical predictor of mortality if it is single-
handedly significantly associated with —or able to pre-
dict— mortality. Thus, a laboratory test is only considered
if it reflects a severe single- or multi-organ dysfunction.
However, with this practice, we miss the opportunity to
detect moderate organ dysfunction that may not impact
mortality by itself, but that may have adverse conse-
quences when combined with moderate or severe dys-
function in other organs [17, 24, 28]. Using FI-OutRef to
assess overall organism dysfunction improves our estimate
of biological aging as well as overall prognosis of the pa-
tient. The accumulation of deficiencies in aging, which
can be assessed in laboratory tests by FI-Lab in
community-dwelling people [27, 28, 30], is highly related
to declining recovery time after stress-induced damage
[55]. Assessing the advancement of biological aging is an
essential supplement to the clinically available organ-
specific and disease-specific biomarkers associated with
mortality, for example cardiac troponin-tropomyosin inacute myocardial infarction [56, 57]. Such improvement is
especially important due to the rapid increase in the popu-
lation of medical patients above 65 years of age along with
their high heterogeneity in multi-morbidity and advance-
ment of biological aging [18, 58].
Few studies have examined how routine laboratory test
results are associated with post-discharge mortality in
unselected patient cohorts. Walter et al. reported that
high creatinine and low albumin at admission were asso-
ciated with mortality within one year post-discharge in a
non-selected group of medical patients over 70 years of
age [59]. Among older patients with acute hospitalisa-
tions due to heart failure, Novack et al. found that ab-
normal albumin, blood urea nitrogen, sodium, uric acid,
and white blood cell count levels were related to mortal-
ity within one year after discharge [60].
In a situation of acute disease or injury, a given labora-
tory test result can remain within its normal reference
interval (homeostatic equilibrium) only if there is suffi-
cient reserve capacity of the involved organs. Compared
with individual test results, a high FI-OutRef is likely to
reflect a higher number of organs with disturbed
homeostatic balance, and thus potentially reflects the
overall advancement of the patient’s biological aging.
This is supported by the fact that FI-OutRef remained
significantly associated with time to death post-discharge
in multiple Cox regression analyses, even after adjust-
ment for the seven individual laboratory test results that
showed the highest differences in post-discharge propor-
tions of death, being inside versus outside the reference
interval.
Among the five investigated markers, FI-OutRef was
the only marker with discriminative ability by its quar-
tiles in the cumulative incidence plots of post-discharge
death for patients with and without cancer diagnoses.
FI-OutRef may be more sensitive for assessing the ad-
vancement of biological aging at the organism level
compared with number of chronic diagnoses, which may
reflect organ-specific dysfunction, but with a relatively
preserved reserve capacity at the organism level. More-
over, chronic disease documentation may be biased by
economic and subjective incentives and, if well treated;
chronic disease may have less impact on mortality des-
pite representing organ dysfunction and morbidity. Age,
regardless of adjustment for the other markers and sex,
showed a significant association with post-discharge
time to death. The hazard ratios for age quartiles were
almost of the same magnitude as those for FI-OutRef,
indicating aspects of aging beyond those investigated in
the current study.
Between the markers of new chronic diagnoses and
new acute admissions, reflecting the rate of morbidity,
and disease severity and impairment, respectively, new
acute admissions had the higher hazard ratio for all of
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among patients without a cancer diagnosis. Aside from
FI-OutRef, new acute admissions was the only marker
that showed any discriminative ability for cumulative in-
cidence of post-discharge death in patients with a cancer
diagnosis. As we used death as a surrogate measurement
for biological aging, the impact of a new chronic diagno-
sis may have been reduced by relevant medical interven-
tions. Accordingly, the need for acute admission may
have better reflected low physical reserve capacity in this
non-selected population of patients with acute diseases.
This was underlined by the high reduction in the hazard
ratio for new chronic diagnoses with regard to post-
discharge time to death following adjustment for new
acute admissions.
Strengths and limitations
This study had several major strengths. First, this was an
unselected cohort study with complete follow-up. Sec-
ond, for each patient, data were collected from 10 years
before inclusion until 3 years after discharge. Finally, the
study results are highly clinically relevant, as the investi-
gated laboratory tests are objectively assessed as part of
routine practice in most emergency departments in de-
veloped countries. Thus, implementation of FI-OutRef
would not place additional demands on the emergency
department’s manpower, and as such, would support
equality in healthcare.
Our study also had several limitations. First, the re-
corded diagnoses were only obtained from hospital admis-
sions and outpatient clinics. Although these would be the
diagnoses available to the clinical staff at hospital admis-
sion, it is possible that the numbers of diagnoses were
underestimated. Second, some patients were missing la-
boratory test data. However, the results were not altered
in the analyses of the four other markers among patients
who were not missing FI-OutRef values. Imputation of
missing value and latent variable modelling may have im-
proved the laboratory tests’ association with long-term
mortality but it would compromise their feasibility in a
clinical setting. Third, accidental deaths were not identi-
fied, which could bias time to death as a surrogate meas-
urement of biological aging. Even though morbidity and
hospitalisation are risk factors of suicide [61], the absolute
numbers of suicides and accidents are small, representing
0.09% and 1.7% of the death causes respectively within the
age group in Denmark in 2010 [62]. Finally, the only feas-
ible surrogate measurement for biological aging was time
to death within 3 years after discharge. It is possible that
other measures, such as measures of physical and cogni-
tive function, could better reflect the progression in bio-
logical aging and be of greater clinical relevance for
rehabilitation and care intensity.Conclusions and perspectives
In a population of acutely admitted patients who were 65
years of age or older, we demonstrated that the abbrevi-
ated form of FI-lab; FI-OutRef – based on the number of
admission laboratory test results outside of the reference
interval, was strongly associated with long-term mortality
post-discharge. This association was independent of sex
and other known or possible prognostic markers of bio-
logical aging, including age, number of chronic diagnoses,
new chronic diagnoses and new acute admissions. Each of
the five investigated markers was a significant risk factor
associated with time to death within 3 years following dis-
charge, when taking account of sex and the other markers.
Among the five markers FI-OutRef showed the highest
potential for identifying advanced biological aging, mea-
sured as the hazard ratio for post-discharge time to death
relative to its quartiles.
The current findings warrant further examination of
these long-term mortality markers that can be assessed at
low cost and with little manpower. Future studies should
investigate their associations with additional measure-
ments related to quality of life and aging, such as mobility,
and physical and cognitive performance. Implementation
of an objective systematic assessment of biological aging
progression within a clinical setting, such as an emergency
department, requires determining which clinical assess-
ment tools provide added predictive value, by identifying
the smallest cluster of aging-related variables with min-
imal manpower demands. In line with the existing work of
accumulated deficiency and homeostatic physiological
dysregulation in aging, these assessment tools need to
cover different body systems to potentially assess risk of
late-life complications across acute illnesses, chronic dis-
eases, and social inequality, all of which are highly import-
ant for optimising treatment and care among the
increasing population of older individuals.
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